Product/Service

Albumin Fusion Technology

Source: Novozymes Biopharma US Inc.

AlbuminFusionTechnology
Our proprietary technology provides molecular fusion of albumin to protein drug candidates for improved half-life and bioavailability. Albumin fusion technology is a natural alternative to PEGylation.

Click Here To Download:
Brochure: Albumin Fusion Technology

Our proprietary technology provides molecular fusion of albumin to protein drug candidates for improved half-life and bioavailability. Albumin fusion technology is a natural alternative to PEGylation.

Combine albufuse with our yeast expression technology and cGMP/Q7-manufacturing services to maximize the benefits of working with us.

Key benefits

  • Increased half-life of the active molecule, resulting in:
    • Less frequent administration
    • Increased bioavailability therefore lowered dosage
  • Fewer side effects with improved tolerance
  • Competitive production costs
  • Specific albumin fusion binding matrices available for improved downstream purification
  • Animal-free
  • Genetically fused.

Application areas

  • Protein drug half-life extension and delivery technologies
  • Protein expression.

Click Here To Download:
Brochure: Albumin Fusion Technology